Patents by Inventor Anshu M. Roy

Anshu M. Roy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF USING BIOTHIONOL AND BIOTHIONOL-LIKE COMPOUNDS AS ANTI-ANGIOGENIC AGENTS
    Publication number: 20150164873
    Abstract: The present disclosure relates generally to treating or preventing diseases associated with angiogenesis by administering to a patient certain compounds found to inhibit or substantially reduce angiogenesis. Compounds employed according to the present disclosure exhibit good anti-angiogenic activity as well as demonstrate a prophylactic effect for preventing and substantially reducing angiogenesis. Examples of such compounds include Ritanserin, Amiodarone, Terfenadinc, Perphenazine, Bithionol, and Clomipramine.
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Inventors: Zhican Qu, Anshu M. Roy, Subramaniam Ananthan
  • Method of using biothionol and biothionol-like compounds as anti-angiogenic agents
    Patent number: 8367737
    Abstract: The present disclosure relates generally to treating or preventing diseases associated with angiogenesis by administering to a patient certain compounds found to inhibit or substantially reduce angiogenesis. Compounds employed according to the present disclosure exhibit good anti-angiogenic activity as well as demonstrate a prophylactic effect for preventing and substantially reducing angiogenesis. Examples of such compounds include Ritanserin, Amiodarone, Terfenadinc, Perphenazine, Bithionol, and Clomipramine.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: February 5, 2013
    Assignee: Southern Research Institute
    Inventors: Zhican Qu, Anshu M. Roy, Subramaniam Ananthan
  • ANTI-ANGIOGENIC AGENTS AND METHODS OF USE
    Publication number: 20100120745
    Abstract: The present disclosure relates generally to treating or preventing diseases associated with angiogenesis by administering to a patient certain compounds found to inhibit or substantially reduce angiogenesis. Compounds employed according to the present disclosure exhibit good anti-angiogenic activity as well as demonstrate a prophylactic effect for preventing and substantially reducing angiogenesis. Examples of such compounds include Ritanserin, Amiodarone, Terfenadine, Perphenazine, Bithionol, and Clomipramine.
    Type: Application
    Filed: October 9, 2009
    Publication date: May 13, 2010
    Applicant: Southern Research Institute
    Inventors: Zhican Qu, Anshu M. Roy, Subramaniam Ananthan